9-98773931-C-T
Variant names:
Variant summary
Our verdict is Benign. The variant received -19 ACMG points: 0P and 19B. BP4_ModerateBP6_Very_StrongBP7BS1BS2
The NM_173551.5(ANKS6):c.1767G>A(p.Ala589Ala) variant causes a synonymous change involving the alteration of a non-conserved nucleotide. The variant allele was found at a frequency of 0.0018 in 1,599,078 control chromosomes in the GnomAD database, including 45 homozygotes. In-silico tool predicts a benign outcome for this variant. Variant has been reported in ClinVar as Likely benign (★★).
Frequency
Genomes: 𝑓 0.0088 ( 21 hom., cov: 32)
Exomes 𝑓: 0.0011 ( 24 hom. )
Consequence
ANKS6
NM_173551.5 synonymous
NM_173551.5 synonymous
Scores
2
Clinical Significance
Conservation
PhyloP100: -0.476
Publications
0 publications found
Genes affected
ANKS6 (HGNC:26724): (ankyrin repeat and sterile alpha motif domain containing 6) This gene encodes a protein containing multiple ankyrin repeats and a SAM domain. It is thought that this protein may localize to the proximal region of the primary cilium, and may play a role in renal and cardiovascular development. Mutations in this gene have been shown to cause a form of nephronophthisis (NPHP16), a chronic tubulo-interstitial nephritis. [provided by RefSeq, Jul 2015]
ANKS6 Gene-Disease associations (from GenCC):
- nephronophthisis 16Inheritance: AR Classification: DEFINITIVE, STRONG Submitted by: ClinGen, Labcorp Genetics (formerly Invitae)
- nephronophthisis 1Inheritance: AR Classification: SUPPORTIVE Submitted by: Orphanet
- nephronophthisis 2Inheritance: AR Classification: SUPPORTIVE Submitted by: Orphanet
Genome browser will be placed here
ACMG classification
Classification was made for transcript
Our verdict: Benign. The variant received -19 ACMG points.
BP4
Computational evidence support a benign effect (REVEL=0.031).
BP6
Variant 9-98773931-C-T is Benign according to our data. Variant chr9-98773931-C-T is described in ClinVar as Benign/Likely_benign. ClinVar VariationId is 262845.Status of the report is criteria_provided_multiple_submitters_no_conflicts, 2 stars.
BP7
Synonymous conserved (PhyloP=-0.476 with no splicing effect.
BS1
Variant frequency is greater than expected in population afr. GnomAd4 allele frequency = 0.00885 (1345/152022) while in subpopulation AFR AF = 0.0307 (1273/41428). AF 95% confidence interval is 0.0293. There are 21 homozygotes in GnomAd4. There are 655 alleles in the male GnomAd4 subpopulation. Median coverage is 32. This position passed quality control check.
BS2
High Homozygotes in GnomAd4 at 21 AR gene
Transcripts
RefSeq
Ensembl
| Gene | Transcript | HGVSc | HGVSp | Effect | Exon rank | TSL | MANE | Protein | Appris | UniProt |
|---|---|---|---|---|---|---|---|---|---|---|
| ANKS6 | ENST00000353234.5 | c.1767G>A | p.Ala589Ala | synonymous_variant | Exon 9 of 15 | 1 | NM_173551.5 | ENSP00000297837.6 | ||
| ANKS6 | ENST00000375019.6 | c.864G>A | p.Ala288Ala | synonymous_variant | Exon 8 of 15 | 5 | ENSP00000364159.2 | |||
| ANKS6 | ENST00000444472.5 | c.171G>A | p.Ala57Ala | synonymous_variant | Exon 2 of 9 | 2 | ENSP00000398648.1 | |||
| ANKS6 | ENST00000634393.1 | n.867G>A | non_coding_transcript_exon_variant | Exon 7 of 15 | 5 |
Frequencies
GnomAD3 genomes AF: 0.00883 AC: 1342AN: 151904Hom.: 21 Cov.: 32 show subpopulations
GnomAD3 genomes
AF:
AC:
1342
AN:
151904
Hom.:
Cov.:
32
Gnomad AFR
AF:
Gnomad AMI
AF:
Gnomad AMR
AF:
Gnomad ASJ
AF:
Gnomad EAS
AF:
Gnomad SAS
AF:
Gnomad FIN
AF:
Gnomad MID
AF:
Gnomad NFE
AF:
Gnomad OTH
AF:
GnomAD2 exomes AF: 0.00212 AC: 500AN: 235820 AF XY: 0.00160 show subpopulations
GnomAD2 exomes
AF:
AC:
500
AN:
235820
AF XY:
Gnomad AFR exome
AF:
Gnomad AMR exome
AF:
Gnomad ASJ exome
AF:
Gnomad EAS exome
AF:
Gnomad FIN exome
AF:
Gnomad NFE exome
AF:
Gnomad OTH exome
AF:
GnomAD4 exome AF: 0.00105 AC: 1526AN: 1447056Hom.: 24 Cov.: 31 AF XY: 0.000901 AC XY: 649AN XY: 719926 show subpopulations
GnomAD4 exome
AF:
AC:
1526
AN:
1447056
Hom.:
Cov.:
31
AF XY:
AC XY:
649
AN XY:
719926
show subpopulations
African (AFR)
AF:
AC:
1168
AN:
33010
American (AMR)
AF:
AC:
83
AN:
43552
Ashkenazi Jewish (ASJ)
AF:
AC:
0
AN:
25954
East Asian (EAS)
AF:
AC:
0
AN:
38732
South Asian (SAS)
AF:
AC:
13
AN:
84666
European-Finnish (FIN)
AF:
AC:
0
AN:
47740
Middle Eastern (MID)
AF:
AC:
36
AN:
5724
European-Non Finnish (NFE)
AF:
AC:
81
AN:
1107702
Other (OTH)
AF:
AC:
145
AN:
59976
Allele Balance Distribution
Red line indicates average allele balance
Average allele balance: 0.478
Heterozygous variant carriers
0
78
155
233
310
388
0.00
0.20
0.40
0.60
0.80
0.95
Allele balance
Age Distribution
Exome Het
Exome Hom
Variant carriers
0
40
80
120
160
200
<30
30-35
35-40
40-45
45-50
50-55
55-60
60-65
65-70
70-75
75-80
>80
Age
GnomAD4 genome AF: 0.00885 AC: 1345AN: 152022Hom.: 21 Cov.: 32 AF XY: 0.00882 AC XY: 655AN XY: 74292 show subpopulations
GnomAD4 genome
AF:
AC:
1345
AN:
152022
Hom.:
Cov.:
32
AF XY:
AC XY:
655
AN XY:
74292
show subpopulations
African (AFR)
AF:
AC:
1273
AN:
41428
American (AMR)
AF:
AC:
56
AN:
15286
Ashkenazi Jewish (ASJ)
AF:
AC:
0
AN:
3464
East Asian (EAS)
AF:
AC:
0
AN:
5144
South Asian (SAS)
AF:
AC:
0
AN:
4812
European-Finnish (FIN)
AF:
AC:
0
AN:
10582
Middle Eastern (MID)
AF:
AC:
0
AN:
294
European-Non Finnish (NFE)
AF:
AC:
7
AN:
67986
Other (OTH)
AF:
AC:
9
AN:
2114
Allele Balance Distribution
Red line indicates average allele balance
Average allele balance: 0.502
Heterozygous variant carriers
0
67
134
202
269
336
0.00
0.20
0.40
0.60
0.80
0.95
Allele balance
Age Distribution
Genome Het
Genome Hom
Variant carriers
0
20
40
60
80
100
<30
30-35
35-40
40-45
45-50
50-55
55-60
60-65
65-70
70-75
75-80
>80
Age
Alfa
AF:
Hom.:
Bravo
AF:
Asia WGS
AF:
AC:
10
AN:
3478
ClinVar
Significance: Benign/Likely benign
Submissions summary: Benign:5
Revision: criteria provided, multiple submitters, no conflicts
LINK: link
Submissions by phenotype
Nephronophthisis 16 Benign:2
Jan 29, 2025
Labcorp Genetics (formerly Invitae), Labcorp
Significance:Benign
Review Status:criteria provided, single submitter
Collection Method:clinical testing
- -
Mar 09, 2022
ARUP Laboratories, Molecular Genetics and Genomics, ARUP Laboratories
Significance:Benign
Review Status:criteria provided, single submitter
Collection Method:clinical testing
- -
not provided Benign:2
Dec 26, 2020
GeneDx
Significance:Likely benign
Review Status:criteria provided, single submitter
Collection Method:clinical testing
- -
-
Breakthrough Genomics, Breakthrough Genomics
Significance:Likely benign
Review Status:criteria provided, single submitter
Collection Method:not provided
- -
not specified Benign:1
-
PreventionGenetics, part of Exact Sciences
Significance:Benign
Review Status:criteria provided, single submitter
Collection Method:clinical testing
- -
Computational scores
Source:
Name
Calibrated prediction
Score
Prediction
BayesDel_noAF
Benign
DANN
Benign
PhyloP100
RBP_binding_hub_radar
RBP_regulation_power_radar
Splicing
Name
Calibrated prediction
Score
Prediction
SpliceAI score (max)
Details are displayed if max score is > 0.2
Find out detailed SpliceAI scores and Pangolin per-transcript scores at
Publications
You must be logged in to view publications. This limit was set because tens of millions (!) of queries from AI bots are generated daily.